First Time Loading...

Dr Hoenle AG
XETRA:HNL

Watchlist Manager
Dr Hoenle AG Logo
Dr Hoenle AG
XETRA:HNL
Watchlist
Price: 20 EUR -0.99%
Updated: Apr 24, 2024

Intrinsic Value

Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. [ Read More ]

The intrinsic value of one HNL stock under the Base Case scenario is 23.45 EUR. Compared to the current market price of 20 EUR, Dr Hoenle AG is Undervalued by 15%.

Key Points:
HNL Intrinsic Value
Base Case
23.45 EUR
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dr Hoenle AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HNL stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Dr Hoenle AG

Provide an overview of the primary business activities
of Dr Hoenle AG.

What unique competitive advantages
does Dr Hoenle AG hold over its rivals?

What risks and challenges
does Dr Hoenle AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dr Hoenle AG.

Provide P/S
for Dr Hoenle AG.

Provide P/E
for Dr Hoenle AG.

Provide P/OCF
for Dr Hoenle AG.

Provide P/FCFE
for Dr Hoenle AG.

Provide P/B
for Dr Hoenle AG.

Provide EV/S
for Dr Hoenle AG.

Provide EV/GP
for Dr Hoenle AG.

Provide EV/EBITDA
for Dr Hoenle AG.

Provide EV/EBIT
for Dr Hoenle AG.

Provide EV/OCF
for Dr Hoenle AG.

Provide EV/FCFF
for Dr Hoenle AG.

Provide EV/IC
for Dr Hoenle AG.

Show me price targets
for Dr Hoenle AG made by professional analysts.

What are the Revenue projections
for Dr Hoenle AG?

How accurate were the past Revenue estimates
for Dr Hoenle AG?

What are the Net Income projections
for Dr Hoenle AG?

How accurate were the past Net Income estimates
for Dr Hoenle AG?

What are the EPS projections
for Dr Hoenle AG?

How accurate were the past EPS estimates
for Dr Hoenle AG?

What are the EBIT projections
for Dr Hoenle AG?

How accurate were the past EBIT estimates
for Dr Hoenle AG?

Compare the revenue forecasts
for Dr Hoenle AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dr Hoenle AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dr Hoenle AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dr Hoenle AG compared to its peers.

Compare the P/E ratios
of Dr Hoenle AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Dr Hoenle AG with its peers.

Analyze the financial leverage
of Dr Hoenle AG compared to its main competitors.

Show all profitability ratios
for Dr Hoenle AG.

Provide ROE
for Dr Hoenle AG.

Provide ROA
for Dr Hoenle AG.

Provide ROIC
for Dr Hoenle AG.

Provide ROCE
for Dr Hoenle AG.

Provide Gross Margin
for Dr Hoenle AG.

Provide Operating Margin
for Dr Hoenle AG.

Provide Net Margin
for Dr Hoenle AG.

Provide FCF Margin
for Dr Hoenle AG.

Show all solvency ratios
for Dr Hoenle AG.

Provide D/E Ratio
for Dr Hoenle AG.

Provide D/A Ratio
for Dr Hoenle AG.

Provide Interest Coverage Ratio
for Dr Hoenle AG.

Provide Altman Z-Score Ratio
for Dr Hoenle AG.

Provide Quick Ratio
for Dr Hoenle AG.

Provide Current Ratio
for Dr Hoenle AG.

Provide Cash Ratio
for Dr Hoenle AG.

What is the historical Revenue growth
over the last 5 years for Dr Hoenle AG?

What is the historical Net Income growth
over the last 5 years for Dr Hoenle AG?

What is the current Free Cash Flow
of Dr Hoenle AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dr Hoenle AG.

Financials

Balance Sheet Decomposition
Dr Hoenle AG

Current Assets 62m
Cash & Short-Term Investments 8.6m
Receivables 15.8m
Other Current Assets 37.7m
Non-Current Assets 106m
Long-Term Investments 1.4m
PP&E 74.1m
Intangibles 19.6m
Other Non-Current Assets 10.9m
Current Liabilities 28.3m
Accounts Payable 6.5m
Other Current Liabilities 21.8m
Non-Current Liabilities 46.4m
Long-Term Debt 41.8m
Other Non-Current Liabilities 4.7m
Efficiency

Earnings Waterfall
Dr Hoenle AG

Revenue
130.1m EUR
Cost of Revenue
-62.5m EUR
Gross Profit
67.6m EUR
Operating Expenses
-77.7m EUR
Operating Income
-10.1m EUR
Other Expenses
-1.8m EUR
Net Income
-11.9m EUR

Free Cash Flow Analysis
Dr Hoenle AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

HNL Profitability Score
Profitability Due Diligence

Dr Hoenle AG's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
34/100
Profitability
Score

Dr Hoenle AG's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

HNL Solvency Score
Solvency Due Diligence

Dr Hoenle AG's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
42/100
Solvency
Score

Dr Hoenle AG's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HNL Price Targets Summary
Dr Hoenle AG

Wall Street analysts forecast HNL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HNL is 26.72 EUR with a low forecast of 23.63 EUR and a high forecast of 30.45 EUR.

Lowest
Price Target
23.63 EUR
18% Upside
Average
Price Target
26.72 EUR
34% Upside
Highest
Price Target
30.45 EUR
52% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

HNL Price
Dr Hoenle AG

1M 1M
+4%
6M 6M
+17%
1Y 1Y
+3%
3Y 3Y
-58%
5Y 5Y
-63%
10Y 10Y
+61%
Annual Price Range
20
52w Low
15.35
52w High
24.4
Price Metrics
Average Annual Return -17.52%
Standard Deviation of Annual Returns 34.47%
Max Drawdown -80%
Shares Statistics
Market Capitalization 121.8m EUR
Shares Outstanding 6 061 854
Percentage of Shares Shorted
N/A

HNL Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Dr Hoenle AG Logo
Dr Hoenle AG

Country

Germany

Industry

Electrical Equipment

Market Cap

121.8m EUR

Dividend Yield

0%

Description

Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. The company is headquartered in Graefelfing, Bayern and currently employs 657 full-time employees. The company went IPO on 2008-02-25. The firm develops, manufactures and supplies ultraviolet (UV) equipment. The firm operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The firm is globally active, with over 69 locations in 27 countries.

Contact

BAYERN
Graefelfing
Lochhamer Schlag 1
+4989856080.0
https://www.hoenle.de/

IPO

2008-02-25

Employees

657

Officers

Chairman of the Management Board, MD & CEO
Dr. Franz Richter
Head of Investor Relations
Peter Weinert

See Also

Discover More
What is the Intrinsic Value of one HNL stock?

The intrinsic value of one HNL stock under the Base Case scenario is 23.45 EUR.

Is HNL stock undervalued or overvalued?

Compared to the current market price of 20 EUR, Dr Hoenle AG is Undervalued by 15%.